Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies
Patients with myotonic dystrophy need to undergo invasive muscle biopsies to monitor disease progression and response to therapy. Here, the authors show that extracellular RNAs in human urine can be used as biomarkers to differentiate patients from unaffected controls, and to monitor exon skipping i...
Guardado en:
Autores principales: | Layal Antoury, Ningyan Hu, Leonora Balaj, Sudeshna Das, Sofia Georghiou, Basil Darras, Tim Clark, Xandra O. Breakefield, Thurman M. Wheeler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a34cd40d232146518807809a9a2dd9f6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
por: Ningyan Hu, et al.
Publicado: (2018) -
Evaluation of muscular changes by ultrasound Nakagami imaging in Duchenne muscular dystrophy
por: Wen-Chin Weng, et al.
Publicado: (2017) -
PABPN1 gene therapy for oculopharyngeal muscular dystrophy
por: A. Malerba, et al.
Publicado: (2017) -
Computer task performance by subjects with Duchenne muscular dystrophy
por: Malheiros SRP, et al.
Publicado: (2015) -
Current and emerging treatment strategies for Duchenne muscular dystrophy
por: Mah JK
Publicado: (2016)